These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7460483)

  • 1. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of cimetidine in man.
    Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
    Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of cimetidine.
    Grahnén A; von Bahr C; Lindström B; Rosén A
    Eur J Clin Pharmacol; 1979 Nov; 16(5):335-40. PubMed ID: 520401
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic encephalopathy and altered cimetidine kinetics.
    Ziemniak JA; Bernhard H; Schentag JJ
    Clin Pharmacol Ther; 1983 Sep; 34(3):375-82. PubMed ID: 6883913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
    Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
    Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.
    Bodemar G; Norlander B; Fransson L; Walan A
    Br J Clin Pharmacol; 1979 Jan; 7(1):23-31. PubMed ID: 760739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phenobarbital treatment on cimetidine kinetics.
    Somogyi A; Thielscher S; Gugler R
    Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.